| pubmed-article:18266660 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18266660 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18266660 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:18266660 | lifeskim:mentions | umls-concept:C0235480 | lld:lifeskim |
| pubmed-article:18266660 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:18266660 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:18266660 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18266660 | pubmed:dateCreated | 2008-6-16 | lld:pubmed |
| pubmed-article:18266660 | pubmed:abstractText | To test the hypothesis that stroke and systemic embolic events (SEE) in the stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) III and V trials are different between paroxysmal and persistent atrial fibrillation (AF). | lld:pubmed |
| pubmed-article:18266660 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18266660 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18266660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18266660 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18266660 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18266660 | pubmed:issn | 1365-2796 | lld:pubmed |
| pubmed-article:18266660 | pubmed:author | pubmed-author:FrisonLL | lld:pubmed |
| pubmed-article:18266660 | pubmed:author | pubmed-author:GrindMM | lld:pubmed |
| pubmed-article:18266660 | pubmed:author | pubmed-author:LipG Y HGY | lld:pubmed |
| pubmed-article:18266660 | pubmed:author | pubmed-author:SPORTIF... | lld:pubmed |
| pubmed-article:18266660 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18266660 | pubmed:volume | 264 | lld:pubmed |
| pubmed-article:18266660 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18266660 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18266660 | pubmed:pagination | 50-61 | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:meshHeading | pubmed-meshheading:18266660... | lld:pubmed |
| pubmed-article:18266660 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18266660 | pubmed:articleTitle | Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation. | lld:pubmed |
| pubmed-article:18266660 | pubmed:affiliation | University Department of Medicine, City Hospital, Birmingham, B18 7QH, United Kingdom. g.y.h.lip@bham.ac.uk | lld:pubmed |
| pubmed-article:18266660 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18266660 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18266660 | lld:pubmed |
